The clinical use of 131I-meta-iodo-benzylguanidine (MIBG) for the diagnosis of neuroblastoma

Med Pregl. 1993:46 Suppl 1:74-5.

Abstract

Whole-body scintigraphy with 131I-meta-iodo-benzylguanidine 131I-MIBG) was performed in 41 patients with neuroblastoma. In patients with clinical remission no pathological concentration of 131I-MIBG was found. In 30 patients with residual, recurrent or metastatic disease neuroblastoma was correctly localized by 131I-MIBG scintigraphy. It is concluded that 131I-MIBG whole-body scintigraphy is useful in the diagnosis and follow-up of neuroblastoma.

MeSH terms

  • 3-Iodobenzylguanidine
  • Child
  • Child, Preschool
  • Contrast Media
  • Female
  • Humans
  • Infant
  • Iodine Radioisotopes*
  • Iodobenzenes*
  • Male
  • Neuroblastoma / diagnostic imaging*
  • Radionuclide Imaging

Substances

  • Contrast Media
  • Iodine Radioisotopes
  • Iodobenzenes
  • 3-Iodobenzylguanidine